A Phase 2b, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous MEDI-528 in Adults With Uncontrolled Asthma.

Trial Profile

A Phase 2b, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous MEDI-528 in Adults With Uncontrolled Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2014

At a glance

  • Drugs Enokizumab (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Aug 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
    • 20 May 2012 Results reported at the 108th International Conference of the American Thoracic Society.
    • 01 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top